Impact of Universal Immunization Program With Monoclonal Antibody Nirsevimab on Reducing the Burden of Serious Bronchiolitis That Need Pediatric Intensive Care
- Carme Alejandre; Daniel Penela-Sánchez; Judit Alsina; Marta Agüera; Aleix Soler; Sara Moussalam
Access Resources
About
This study in Catalonia, Spain analyzed the effects of immunizing children with nirsevimab on bronchiolitis cases in pediatric intensive care units (PICU). The research compared pre- and post-nirsevimab periods, showing a significant decrease in PICU admissions for bronchiolitis, shorter hospital stays, and older age at admission post-nirsevimab implementation. This suggests that nirsevimab plays a crucial role in reducing RSV bronchiolitis cases in hospitals.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.